NCT02707341Recruiting
The CorEvitas Psoriasis (PSO) Registry
CorEvitas Psoriasis (PSO) Registry
Source: ClinicalTrials.gov · Last updated 27 Aug 2026
Brief summary (registry, in English)
The primary objective of the CorEvitas Psoriasis Registry is to study the comparative safety of approved psoriasis therapies in a North American cohort of psoriasis subjects treated by dermatologists. This includes assessing the incidence and nature of adverse events of special interest, including malignancy, in a real world population of psoriasis patients on new biologic therapies (e.g. secukinumab). Secondary objectives include analyzing the epidemiology and natural history of the disease, comorbidities, current treatment practices, and comparative effectiveness.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 10000 (estimated)
- First submitted
- 4 May 2015
- Start date
- 1 Apr 2015
- Primary completion date
- 31 Dec 2100
- Lead sponsor
- CorEvitas
- Diseases
- Psoriasis
- NCT number
- NCT02707341
What you commit to
- Study type: Observational
- Planned participants: 10000
- From 1 Apr 2015 to the primary completion date, 31 Dec 2100
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- 1\. Patient is participating in or planning to participate in a double-blind randomized of a psoriasis drug. Of note, concurrent participation in another observational registry or open-label Phase 3b/4 trial is not excluded.
Who the study is looking for
- The patient must:
- Have been diagnosed with psoriasis by a dermatologist.
- Be at least 18 years of age or older.
- Be willing and able to provide written consent for participation in the registry.
- Be willing and able to provide Personally Identifiable Information (PII) that includes the following types of personal information at a minimum: 1) Full Name and 2) Date of Birth.
- Meet one of the following criteria.
- Have started on or switched to a systemic psoriasis treatment within the previous 12 months†▲:
Criteria the registry did not label
- ELIGIBILITY CRITERIA∗ To be eligible for enrollment into the CorEvitas Psoriasis Registry, a patient must satisfy all of the inclusion criteria and none of the exclusion criteria listed below.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| - Coordinator of this site? Confirm its status | Waltham | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.